GlaxoSmithKline Plc reported an 8% drop in group turnover in the third quarter of 2012 to £6.5 billion, a result that was significantly affected by government austerity measures in Europe and the impact of reference pricing in the region. ---Subscribe to MedNous to access this article--- Company News
